Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.46 is 55% below its 5-year average of 7.76, near the low end of its 5-year range (3.46–16.17).
As of the fiscal period ended Tuesday, June 30, 2026. 15.90% below its 12-month average of 4.12.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.46.
CURRENT RATIO
3.46
CURRENT RATIO AVG TTM
4.12
CURRENT RATIO AVG 3Y
5.03
CURRENT RATIO AVG 5Y
7.76
CURRENT RATIO AVG 10Y
8.62
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-15.90%
CURRENT VS 3Y AVG
-31.17%
CURRENT VS 5Y AVG
-55.42%
CURRENT VS 10Y AVG
-59.83%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.48
median of 691 covered companies
CURRENT VS SECTOR MEDIAN
-0.52%
vs the sector median at left
Aclaris Therapeutics, Inc.
Market Cap
$558.65M
Current Ratio
3.46
TTM Avg
4.12
3Y Avg
5.03
5Y Avg
7.76
Market Cap
$567.12M
Current Ratio
9.36
TTM Avg
2.17
3Y Avg
1.76
5Y Avg
2.63
Market Cap
$555.16M
Current Ratio
5.42
TTM Avg
12.18
3Y Avg
12.18
5Y Avg
12.18
Market Cap
$576.52M
Current Ratio
7.19
TTM Avg
3.91
3Y Avg
2.77
5Y Avg
2.56
Market Cap
$538.58M
Current Ratio
25.13
TTM Avg
6.17
3Y Avg
7.34
5Y Avg
19.91
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | $558.65M | 3.46 | 4.12 | 5.03 | 7.76 |
| CorMedix Inc. (CRMD)vs › | $566.03M | 2.56 | 2.75 | 5.48 | 7.66 |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $567.12M | 9.36 | 2.17 | 1.76 | 2.63 |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $555.16M | 5.42 | 12.18 | 12.18 | 12.18 |
| Nuvectis Pharma, Inc. (NVCT)vs › | $556.87M | 1.68 | 2.23 | 2.63 | 2.59 |
| Aquestive Therapeutics, Inc. (AQST)vs › | $576.52M | 7.19 | 3.91 | 2.77 | 2.56 |
| Delcath Systems, Inc. (DCTH)vs › | $540.95M | 9.83 | 11.46 | 6.57 | 5.79 |
| Immix Biopharma, Inc. (IMMX)vs › | $538.58M | 25.13 | 6.17 | 7.34 | 19.91 |
| OrthoPediatrics Corp. (KIDS)vs › | $588.70M | 4.78 | 6.27 | 6.33 | 5.72 |
Current Ratio
3.46
Quick Ratio
3.46
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.46 |
| 2026-03-31 | 4.03 |
| 2025-12-31 | 5.28 |
| 2025-09-30 | 3.92 |
| 2025-06-30 | 3.88 |
| 2025-03-31 | 5.06 |
| 2024-12-31 | 3.99 |
| 2024-09-30 | 7.03 |
| 2024-06-30 | 7.50 |
| 2024-03-31 | 6.74 |
| 2023-12-31 | 4.16 |
| 2023-09-30 | 4.50 |
| 2023-06-30 | 5.82 |
| 2023-03-31 | 10.10 |
| 2022-12-31 | 10.55 |
| 2022-09-30 | 12.97 |
| 2022-06-30 | 15.99 |
| 2022-03-31 | 11.41 |
| 2021-12-31 | 8.94 |
| 2021-09-30 | 11.54 |
| 2021-06-30 | 16.17 |
| 2021-03-31 | 9.27 |
| 2020-12-31 | 3.87 |
| 2020-09-30 | 4.54 |
| 2020-06-30 | 4.00 |
| 2020-03-31 | 4.01 |
| 2019-12-31 | 3.74 |
| 2019-09-30 | 3.73 |
| 2019-06-30 | 3.23 |
| 2019-03-31 | 4.33 |
| 2018-12-31 | 6.56 |
| 2018-09-30 | 6.53 |
| 2018-06-30 | 8.53 |
| 2018-03-31 | 13.91 |
| 2017-12-31 | 16.37 |
| 2017-09-30 | 23.43 |
| 2017-06-30 | 21.00 |
| 2017-03-31 | 27.91 |
| 2016-12-31 | 27.98 |
| 2016-09-30 | 18.64 |
| 2016-06-30 | 17.37 |
| 2016-03-31 | 23.29 |
| 2015-12-31 | 59.19 |
| 2015-09-30 | 20.25 |
| 2015-06-30 | 7.33 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 11.26 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
